Sosei Acquires GPCR Firm Heptares | Chemical & Engineering News
Volume 93 Issue 9 | p. 16 | Concentrates
Issue Date: March 2, 2015

Sosei Acquires GPCR Firm Heptares

Department: Business
Keywords: pharmaceuticals, biotech, M&A, GPCRs

Japan’s Sosei Group has agreed to acquire London-based Heptares Therapeutics, a private company that develops small molecules and biologics targeting G protein-coupled receptors. Heptares shareholders score $180 million in cash and could get an additional $220 million in milestone payments. Sosei gains a pipeline of drugs to treat neurological and metabolic diseases and a structure-based drug design platform. Sosei says Heptares will position it for the loss of patent protection on two of its respiratory products marketed by Novartis.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment